Annexon Biosciences (ANNX) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Annexon Biosciences (ANNX) Company Statistics | The Fly

Annexon Biosciences

· ANNX

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

782.962 M

+2.42%

General

Market Cap: $782.96M
Enterprise Value: $518.43M
Shares Outstanding: —
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -82.36%
ROE: -106.15%
ROIC: -99.93%
Current Ratio: 5.53
Debt-to-Equity: 0.13
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 3.72
EV/EBITDA: -2.60

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $208.65M
Operating Income: -$210.56M
Net Profit: -$202.67M

Balance Sheet

Cash and Equivalents: $199.27M
Working Capital: $174.28M
Total Assets: $246.07M
Net Debt: -$174.62M
Total Liabilities: $60.01M
Total Equity: $186.06M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$193.03M
Cash Flow from Investing: $86.37M
Cash Flow from Financing: $173.64M
Free Cash Flow: -$193.22M
Capital Expenditures: $185K